期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Whole Lung Lavage Treatment of Chinese Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Long-term Follow-up Study 被引量:2
1
作者 Yu-Yue Zhao Hui Huang Yong-Zhe Liu Xin-Yu Song Shan Li Zuo-Jun Xu 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第20期2714-2719,共6页
Background: Pulmonary alveolar proteinosis (PAP) is a rare lung disease, the most common type of which is autoimmune PAP. The gold standard therapy for PAP is whole lung lavage (WLL). Few studies have reported th... Background: Pulmonary alveolar proteinosis (PAP) is a rare lung disease, the most common type of which is autoimmune PAP. The gold standard therapy for PAP is whole lung lavage (WLL). Few studies have reported the optimal technique with which to evaluate the response to WLL. In this study, we aimed to identify parameters with which to assess the need for repeat WLL during a long-term 8-year follow-up. Methods: We conducted a retrospective analysis of 120 patients with autoimmune PAP with 80 of whom underwent WLL. Physiologic, serologic, and radiologic features of the patients were analyzed during an 8-year follow-up after the first WLL treatment. Results: Of the 40 patients without any intervention, 39 patients either achieved remission or remained stable and only one died of pulmonary infection. Of the 56 patients who underwent WLL for 1 time, 55 remained free from a second WLL and 1 patient died of cancer. Twenty-four required additional treatments after their first WLL. The baseline PaO2, (P = 0.000), PA-aO2 (P = 0.000), shunt fraction rate (P = 0.001), percent of predicted normal diffusing capacity of the lung for carbon monoxide (DLCO%Pred) (P = 0.016), 6-rain walk test (P = 0.013), carcinoembryonic antigen (CEA) (P = 0.007), and neuron-specific enolase (NSE) (P = 0.003) showed significant differences among the three groups. The need for a second WLL was significantly associated with PaO2 (P = 0.000), CEA (P= 0.050), the 6-minute walk test (P= 0.026), and DLCO%Pred (P = 0.041 ). The DLCO%Pred on admission with a cut-off value of42.1% (P = 0.001) may help to distinguish whether patients with PAP require a second WLL. Conclusions: WLL is the optimal treatment method for PAP and provides remarkable improvements for affected patients. The DLCO%Pred on admission with a cut-offvalue of 42.1% may distinguish whether patients with PAP require a second WLL. 展开更多
关键词 Diffusing Capacity of the lung fbr Carbon Monoxide PROGNOSIS Pulmonary Alveolar Proteinosis Treatment:whole lung lavage
原文传递
Pulmonary alveolar proteinosis associated with tuberculosis and aspergilloma formation 被引量:2
2
作者 HUANG Xiao-ying YU Chang +4 位作者 XU Xiao-mei YANG Wen-tao ZHANG Xie LIU Pan-pan WANG Liang-xing 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第17期3191-3192,共2页
Pulmonary alveolar proteinosis (PAP) is a rare diffuse lung disease, characterized by accumulation of surfactant-associated phosphor lipoproteinaceous material in the alvoli. Finding the periodic acid-Schiff (PAS)... Pulmonary alveolar proteinosis (PAP) is a rare diffuse lung disease, characterized by accumulation of surfactant-associated phosphor lipoproteinaceous material in the alvoli. Finding the periodic acid-Schiff (PAS) positive substance in the alveolar lavage can help to make the diagnosis. 展开更多
关键词 pulmonary alveolar proteinosis TUBERCULOSIS ASPERGILLOMA whole lung lavage
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部